Pathogens (Apr 2022)

Serological Assays for Alveolar and Cystic Echinococcosis—A Comparative Multi-Test Study in Switzerland and Kyrgyzstan

  • Philipp A. Kronenberg,
  • Ansgar Deibel,
  • Bruno Gottstein,
  • Felix Grimm,
  • Beat Müllhaupt,
  • Cordula Meyer zu Schwabedissen,
  • Sezdbek Aitbaev,
  • Rakhatbek A. Omorov,
  • Kubanychbek K. Abdykerimov,
  • Gulnara Minbaeva,
  • Jumagul Usubalieva,
  • Mar Siles-Lucas,
  • Paola Pepe,
  • Laura Rinaldi,
  • Markus Spiliotis,
  • Junhua Wang,
  • Norbert Müller,
  • Paul R. Torgerson,
  • Peter Deplazes

DOI
https://doi.org/10.3390/pathogens11050518
Journal volume & issue
Vol. 11, no. 5
p. 518

Abstract

Read online

Both alveolar (AE) and cystic echinococcosis (CE) are lacking pathognomonic clinical signs; consequently imaging technologies and serology remain the main pillars for diagnosis. The present study included 100 confirmed treatment-naïve AE and 64 CE patients that were diagnosed in Switzerland or Kyrgyzstan. Overall, 10 native Echinococcus spp. antigens, 3 recombinant antigens, and 4 commercial assays were comparatively evaluated. All native E. multilocularis antigens were produced in duplicates with a European and a Kyrgyz isolate and showed identical test values for the diagnosis of AE and CE. Native antigens and three commercial tests showed high diagnostic sensitivities (Se: 86–96%) and specificities (Sp: 96–99%) for the diagnosis of AE and CE in Swiss patients. In Kyrgyz patients, values of sensitivities and specificities were 10–20% lower as compared to the Swiss patients’ findings. For the sero-diagnosis of AE in Kyrgyzstan, a test-combination of an E. multilocularis protoscolex antigen and the recombinant antigen Em95 appears to be the most suitable test strategy (Se: 98%, Sp: 87%). For the diagnosis of CE in both countries, test performances were hampered by major cross-reactions with AE patients and other parasitic diseases as well as by limited diagnostic sensitivities (93% in Switzerland and 76% in Kyrgyzstan, respectively).

Keywords